1. Home
  2. LUMO

LUMO

Lumos Pharma Inc.

Logo Lumos Pharma Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.

Founded: 2011 Country:
United States
United States
Employees: N/A City: AUSTIN
Market Cap: 22.6M IPO Year: N/A
Target Price: $18.00 AVG Volume (30 days): 21.0K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.18 EPS Growth: N/A
52 Week Low/High: $2.41 - $4.55 Next Earning Date: 05-01-2024
Revenue: $2,051,000 Revenue Growth: 34.67%
Revenue Growth (this year): 338.13% Revenue Growth (next year): -1.94%

Share on Social Networks: